Not Yet Recruiting PHASE2 INTERVENTIONAL 4-arm NCT06942663

Randomized Phase II Trial Evaluating DFS in The Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Gastric Cancer (JAGC1)

Randomized Phase II Trial Evaluating DFS in the Absence of an Adjuvant Component of Perioperative Chemotherapy in Patients With Stage IB-III Gastric Cancer Who Achieved pCR or TRG4-5 on the Mandard Scale on Neoadjuvant Chemotherapy

Sponsor: Nizhny Novgorod Regional Clinical Oncology Center

Conditions Gastric Cancer

Interventions Adjuvant Chemotherapy Surveillance

Updated 1 time since 2025 Last updated: Apr 17, 2025 Started: Apr 15, 2025 Primary completion: Nov 1, 2027 Completion: Nov 1, 2030

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Gastric Cancer and is currently actively recruiting participants. Nizhny Novgorod Regional Clinical Oncology Center leads this study, which shows 1 recorded version since 2025 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — PHASE2 [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Nizhny Novgorod Regional Clinical Oncology Center

Data source: Nizhny Novgorod Regional Clinical Oncology Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.